ResMed (RMD) Tops Q2 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $240.50 +5.91%
Financial Fact:
Income taxes (note 13): 16.82M
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Income taxes (note 13): 16.82M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q2 EPS of $2.81, $0.08 better than the analyst estimate of $2.73. Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.4 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- American Superconductor (AMSC) Misses Q2 EPS by 2c ; Offers Guidance
- AppLovin (APP) Tops Q3 EPS by 26c, Beats on Revenue; Offers Q4 Revenue Guidance
- HubSpot (HUBS) Tops Q3 EPS by 54c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
